{"id":"https://openalex.org/W4362618893","doi":"https://doi.org/10.1158/2326-6066.22539598","title":"Supplementary Figure Legends from Combination Therapy Using Ruxolitinib and Oncolytic HSV Renders Resistant MPNSTs Susceptible to Virotherapy","display_name":"Supplementary Figure Legends from Combination Therapy Using Ruxolitinib and Oncolytic HSV Renders Resistant MPNSTs Susceptible to Virotherapy","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362618893","doi":"https://doi.org/10.1158/2326-6066.22539598"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6066.22539598","doi":"https://doi.org/10.1158/2326-6066.22539598","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.22539598","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/2326-6066.22539598","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084223519","display_name":"Mohammed G. Ghonime","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mohammed G. Ghonime","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5059334176","display_name":"Kevin A. Cassady","orcid":"https://orcid.org/0000-0003-2474-9051","observed_orcids":["https://orcid.org/0000-0003-2474-9051"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kevin A. Cassady","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10625","display_name":"Herpesvirus Infections and Treatments","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ruxolitinib","display_name":"ruxolitinib","score":0.9829999804496765},{"id":"https://openalex.org/keywords/oncolytic-herpes-simplex-virus","display_name":"oncolytic herpes simplex virus","score":0.796999990940094},{"id":"https://openalex.org/keywords/malignant-peripheral-nerve-sheath-tumor","display_name":"malignant peripheral nerve sheath tumor","score":0.7799999713897705},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8619999885559082},{"id":"https://openalex.org/keywords/virotherapy","display_name":"virotherapy","score":0.9079999923706055},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.625},{"id":"https://openalex.org/keywords/epha2","display_name":"EphA2","score":0.6940000057220459},{"id":"https://openalex.org/keywords/cd8-t-cell-activation","display_name":"CD8+ T cell activation","score":0.925000011920929},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.8180000185966492},{"id":"https://openalex.org/keywords/viral-replication","display_name":"viral replication","score":0.7490000128746033}],"concepts":[{"id":"https://openalex.org/C82210918","wikidata":"https://www.wikidata.org/wiki/Q1560099","display_name":"Oncolytic virus","level":3,"score":0.8224616646766663},{"id":"https://openalex.org/C2776112149","wikidata":"https://www.wikidata.org/wiki/Q7383611","display_name":"Ruxolitinib","level":4,"score":0.6081268787384033},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5694512128829956},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.5130857229232788},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.4180942475795746},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3699919581413269},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3676311671733856},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2893258333206177},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.24403107166290283},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.23681151866912842},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.11275684833526611},{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.06770440936088562},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/2326-6066.22539598","doi":"https://doi.org/10.1158/2326-6066.22539598","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.22539598","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/2326-6066.22539598.v1","doi":"https://doi.org/10.1158/2326-6066.22539598.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.22539598.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22539598","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_Legends_from_Combination_Therapy_Using_Ruxolitinib_and_Oncolytic_HSV_Renders_Resistant_MPNSTs_Susceptible_to_Virotherapy/22539598","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/2326-6066.22539598","doi":"https://doi.org/10.1158/2326-6066.22539598","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.22539598","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2897351024","https://openalex.org/W4362546188","https://openalex.org/W4405670919","https://openalex.org/W2519589555","https://openalex.org/W4362568560","https://openalex.org/W2001949418","https://openalex.org/W2139640503","https://openalex.org/W1975653248","https://openalex.org/W3169703653","https://openalex.org/W4361955279"],"abstract_inverted_index":{"Supplementary":[0,10,22,33,46,65],"Table":[1],"1:":[2,12],"Nomenclature":[3],"of":[4],"oncolytic":[5],"HSV-1":[6],"and":[7,38,58,73],"their":[8],"genetics;":[9],"Figure":[11,23,34,47,66],"RUX":[13,37],"does":[14],"not":[15],"impair":[16],"67C-4":[17,68],"MPNST":[18],"tumor":[19,69],"cell":[20,80],"growth;":[21],"2:":[24],"Viral":[25],"replication":[26],"is":[27],"integral":[28],"to":[29],"RUX/C134":[30],"anti-tumor":[31],"effect.;":[32],"3:":[35],"Combined":[36],"C134":[39],"treatment":[40,50],"effect":[41],"on":[42],"the":[43,55,62],"infiltrating":[44],"lymphocytes;":[45],"4:":[48],"Virus":[49],"increases":[51],"CD8":[52,78],"activation":[53,63],"in":[54],"periphery":[56],"(D3)":[57],"combination":[59],"therapy":[60],"maintains":[61],"(D5);":[64],"5:":[67],"cells":[70],"express":[71],"EphA2":[72],"control":[74],"peptide":[75],"doesn't":[76],"induce":[77],"T":[79],"activation.":[81]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-07T00:00:00"}